During the past decade, Rigshospitalet Kardiologisk Klinisk conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rigshospitalet Kardiologisk Klinisk" #1 collaborator was "ActiGraph LLC" with 1 trials as a collaborator, "Almac Clinical Technologies" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Henry Ford Health System" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet Kardiologisk Klinisk" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Congenital Heart Disease" (1 trials) and "Congenital Heart Disease With Fontan Circulation" (1 trials). Many other conditions were trialed in "Rigshospitalet Kardiologisk Klinisk" in a lesser frequency.

Most popular intervention types in "Rigshospitalet Kardiologisk Klinisk" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan 10 mg" (1 trials), "Selexipag" (1 trials) and "macitentan 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet Kardiologisk Klinisk" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Rigshospitalet Kardiologisk Klinisk". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rigshospitalet Kardiologisk Klinisk, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet Kardiologisk Klinisk, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".